|
1
|
Serrano A, Lethe B, Delroisse JM, Lurquin
C, de Plaen E, Brasseur F, Rimoldi D and Boon T: Quantitative
evaluation of the expression of MAGE genes in tumors by limiting
dilution of cDNA libraries. Int J Cancer. 83:664–669. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jungbluth AA, Busam KJ, Kolb D, Iversen K,
Coplan K, Chen YT, Spagnoli GC and Old LJ: Expression of
MAGE-antigens in normal tissues and cancer. Int J Cancer.
85:460–465. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ries J, Schultze-Mosgau S, Neukam F,
Diebel E and Wiltfang J: Investigation of the expression of
melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous
cell carcinomas to determine potential targets for gene-based
cancer immunotherapy. Int J Oncol. 26:817–824. 2005.PubMed/NCBI
|
|
4
|
Ohman Forslund K and Nordqvist K: The
melanoma antigen genes - any clues to their functions in normal
tissues? Exp Cell Res. 265:185–194. 2001.PubMed/NCBI
|
|
5
|
Xiao J and Chen HS: Biological functions
of melanoma-associated antigens. World J Gastroenterol.
10:1849–1853. 2004.PubMed/NCBI
|
|
6
|
Muller-Richter UD, Dowejko A, Zhou W,
Reichert TE and Driemel O: Different expression of MAGE-A-antigens
in foetal and adult keratinocyte cell lines. Oral Oncol.
44:628–633. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Suzuki T, Yoshida K, Wada Y, Hamai Y,
Sentani K, Oue N and Yasui W: Melanoma-associated antigen-A1
expression predicts resistance to docetaxel and paclitaxel in
advanced and recurrent gastric cancer. Oncol Rep. 18:329–336.
2007.PubMed/NCBI
|
|
8
|
Duan Z, Duan Y, Lamendola DE, Yusuf RZ,
Naeem R, Penson RT and Seiden MV: Overexpression of MAGE/GAGE genes
in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin
Cancer Res. 9:2778–2785. 2003.PubMed/NCBI
|
|
9
|
Diaz JF and Andreu JM: Assembly of
purified GDP-tubulin into microtubules induced by taxol and
taxotere: reversibility, ligand stoichiometry and competition.
Biochemistry. 32:2747–2755. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hanauske AR, Degen D, Hilsenbeck SG,
Bissery MC and von Hoff DD: Effects of taxotere and taxol on in
vitro colony formation of freshly explanted human tumor cells.
Anticancer Drugs. 3:121–124. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Müller-Richter UDA, Dowejko A, Reuther T,
Kleinheinz J, Reichert TE and Driemel O: Analysis of expression
profiles of MAGE-A antigens in oral squamous cell carcinoma cell
lines. Head Face Med. 5:102009.PubMed/NCBI
|
|
12
|
Ries J, Vairaktaris E, Mollaoglu N,
Wiltfang J, Neukam FW and Nkenke E: Expression of
melanoma-associated antigens in oral squamous cell carcinoma. J
Oral Pathol Med. 37:88–93. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Figueiredo DL, Mamede RC, Proto-Siqueira
R, Neder L, Silva WA Jr and Zago MA: Expression of cancer testis
antigens in head and neck squamous cell carcinomas. Head Neck.
28:614–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee KD, Lee HH, Joo HB, Lee HS, Yu TH,
Chang HK, Jeon CH and Park JW: Expression of MAGE A 1-6 mRNA in
sputa of head and neck cancer patients - a preliminary report.
Anticancer Res. 26:1513–1518. 2006.PubMed/NCBI
|
|
15
|
Lee KD, Eura M, Ogi K, Nakano K,
Chikamatsu K, Masuyama K and Ishikawa T: Expression of the MAGE-1,
−2, −3, −4 and −6 genes in non-squamous cell carcinoma lesions of
the head and neck. Acta Otolaryngol. 116:633–639. 1996.
|
|
16
|
Kasuga C, Nakahara Y, Ueda S, Hawkins C,
Taylor MD, Smith CA and Rutka JT: Expression of MAGE and GAGE genes
in medulloblastoma and modulation of resistance to chemotherapy.
Laboratory investigation. J Neurosurg Pediatr. 1:305–313. 2008.
View Article : Google Scholar : PubMed/NCBI
|
